Search results
Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024
Digital Journal· 7 days agoAdaptimmune Adaptimmune is a clinical-stage biopharmaceutical company focused on designing, developing, and delivering cell therapies to transform the lives of people with cancer. The Company's ...
Cellipont Bioservices and Adva Biotechnology Collaborate to Optimize Cell Therapy Manufacturing with...
WRBL Columbus· 19 hours agoCellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Adva Biotechnology, an Israel-based private biotechnology company providing a decentralized ...
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
Morningstar· 7 days agoEditas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced a two-year extension to the collaboration with Bristol Myers Squibb (NYSE: BMY) under which the parties ...